Gaming Community by Max Level on MSN
Half-Life 2 writer slams players cheering for game failures
The veteran writer behind releases like Half-Life 2, Portal, and Left 4 Dead, Chet Faliszek, has called out players for being ...
Capcom's sci-fi action game with hacking mechanics now launches a week early, giving it a two-week head start over ...
The FDA assigned a PDUFA target action date of December 22, 2026 –– The NDA is based on positive data from a successful clinical program ...
OK, but I can't be blamed for this one.
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator developing therapies for cardiometabolic, ...
That's not to mention all the singular, culturally impactful games that have round anniversaries this year, such as Street Fighter 2, Duke Nukem 3D, Grand Theft Auto 3, Super Smash Bros. Melee, Super ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 ...
Developer Wildlight pulls the plug on fantasy shooter after failing to retain players long-term. Final content update drops this week before servers go dark forever.
Company will trade on Nasdaq under trading symbol "DMRA" effective March 10, 2026 -- -- On track to submit IND or CTA for DMR-001 in mutant-calreticulin essential thrombocythemia and myelofibrosis ...
Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...
PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...
Detailed price information for Spyre Therapeutics Inc (SYRE-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results